Nanologica AB (publ)
NICA.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$91.07M
Close$
Share Statistics
| Market cap | $91.07 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.58 |
| Beta | -0.07 |
| Outstanding Shares | 293,970,468 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0.8 |
|---|---|
| PEG | 1.54 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$33.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 26, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
$27.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Nanologica AB (publ)
72 employees
CEO: Andreas Bhagwani Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generat...